Neurologist Reveals Insider Information

A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.

By | November 26, 2012

Flickr, jollyUKSidney Gilman, former chair of the neurology department at the University of Michigan Medical School, has been sued by federal authorities for providing a hedge fund information about clinical trials for an Alzheimer’s drug under development by Elan and Wyeth that led to the fund dumping stocks and making more than $270 million.

The man at the head of the investigation is Mathew Martoma, a portfolio manager at hedge fund firm SAC Capital Advisors, although prosecutors are also looking into wrongdoing by the company’s owner Steven Cohen. Martoma is charged with making trades based on information from Gilman. 

 Preet Bharara, the United States attorney who brought the case to court, called the transaction “the most lucrative insider trading scheme ever charged,” in an interview with The New York Times.

Gilman, who is 80, served as a consultant to Martoma, receiving nearly $108,000 for his expertise.  He also helped oversee the Alzheimer’s trial and is accused of providing information regarding, at first, the drug’s positive results, and later, it’s failure, allowing Martoma to invest and pull out at the right times. Lawyers have promised not prosecute Gilman in exchange for his cooperation. However, Gilman may still face disciplinary action by the University of Michigan, who is reviewing the neuroscientist’s actions as a consultant and waiting to hear what additional information is uncovered during the trial.

(Hat tip to ScienceInsider)

Correction (November 26, 2012): Sidney Gilman is a former chair of the neurology department at the University of Michigan Medical School, rather than a current chair, as was written.  The Scientist regrets the error.


Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo


Avatar of: BobD


Posts: 20

November 26, 2012

Dr. Gillman may have just bumped Martha Stewart off the "Clueless Insider Trading Hall of Fame."

Popular Now

  1. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

  2. Inside a Lab Mouse’s High-Fat Diet
  3. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

  4. How Gastric Bypass Can Kill Sugar Cravings
Horizon Discovery
Horizon Discovery
Life Technologies